Chris Denning

Title: Chris Denning: Innovator in Cellular Transduction

Introduction

Chris Denning is a prominent inventor based in Nottingham, GB. He has made significant contributions to the field of cellular transduction, particularly in the delivery of cargo molecules into living cells. With a total of two patents to his name, Denning's work is at the forefront of innovative medical research.

Latest Patents

Denning's latest patents focus on the transduction of cargo molecules into living cells. His inventions include a delivery molecule designed for the transduction of cargo into a cell. This delivery molecule comprises a cargo-binding molecule and/or a cargo, along with a glycosaminoglycan (GAG) binding element capable of binding to GAG on the surface of the cell. Additionally, it features a protein transduction domain. His patents also cover methods of transduction, methods for producing or modifying cargo for transduction, delivery molecules for transduction, and methods of treatment using transduction or utilizing transduced cells.

Career Highlights

Chris Denning is affiliated with the University of Nottingham, where he continues to advance his research in cellular transduction. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Denning collaborates with notable colleagues such as James Dixon and Kevin Morris Shakesheff. Their combined expertise enhances the research and development of innovative solutions in the field.

Conclusion

Chris Denning is a key figure in the realm of cellular transduction, with his inventions paving the way for advancements in medical science. His contributions are vital for the future of therapeutic applications.